(Q43503374)

24 November 2017

title

Gender risk for anaphylactoid reaction to radiographic contrast media (English)

1 reference

24 November 2017

Lang DM

1

1 reference

24 November 2017

Alpern MB

series ordinal

2

1 reference

24 November 2017

Visintainer PF

series ordinal

3

1 reference

24 November 2017

Smith ST

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

The Journal of Allergy and Clinical Immunology

24 November 2017

published in

1 reference

24 November 2017

volume

95

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

813-817

1 reference

Safer, more expensive iodinated contrast agents: how do we decide?

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

The introduction of low-osmolar contrast agents in radiology. Medical, economic, legal, and public policy issues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Increased Risk for Anaphylactoid Reaction from Contrast Media in Patients on β-Adrenergic Blockers or with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Assessment of patients who have experienced anaphylaxis: a 3-year survey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Biphasic and protracted anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Idiopathic anaphylaxis. A clinical summary of 175 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

The current status of reactions to intravenous contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Cardiovascular health and disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Acute damage to human endothelial cells by brief exposure to contrast media in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

Progesterone sensitivity as a cause of recurrent anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2895%2970123-0

7 January 2021

10.1016/S0091-6749(95)70123-0

Identifiers

DOI

1 reference

24 November 2017

1 reference